← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2005Last known activity
Aug 30, 2024
Timeline
1940s
- Jun 1, 1946
Il-Yang Pharm. Co., Ltd.— Founded
Drugs by trial phase (17 distinct, 29 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Bone Marrow Diseases
- Communicable Diseases
- Esophagitis
- Gastroesophageal Reflux
- Gastrointestinal Hemorrhage
- Helicobacter Infections
- Hematologic Diseases
- Infections
- Influenza, Human
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Peptic Ulcer
- Philadelphia Chromosome
- Stomach Neoplasms
Recent trials (35)
- NCT06284876Lead sponsorPhase 3Aug 30, 2024
- NCT06461078Lead sponsorPhase 1Aug 5, 2024
- NCT06471868Lead sponsorPhase 1Jun 10, 2024
- NCT06725992Lead sponsorPhase 1Jan 30, 2024
- NCT06181591CollaboratorPhase 2Jan 15, 2024
- NCT05558150Lead sponsorPhase 1Nov 11, 2022
- NCT05617651Lead sponsorPhase 1Oct 27, 2022
- NCT05509543Lead sponsorPhase 1Aug 24, 2022
- NCT05237297Lead sponsorPhase 1Feb 17, 2022
- NCT04381689Lead sponsorPhase 3Sep 1, 2021
- NCT04691661Lead sponsorPhase 2Aug 24, 2021
- NCT03722420Study directorPhase 3Dec 28, 2018
- NCT03722420Lead sponsorPhase 3Dec 28, 2018
- NCT03444883Lead sponsorPhase 3Aug 31, 2018
- NCT03459534Lead sponsorPhase 3Jun 25, 2018
Details
- Founded
- Gyeonggi-do, KR Jun 1, 1946
- Last known activity
- Aug 30, 2024